These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12532821)

  • 21. Voltage-gated sodium channels: action players with many faces.
    Koopmann TT; Bezzina CR; Wilde AA
    Ann Med; 2006; 38(7):472-82. PubMed ID: 17101538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Paralysis periodica paramyotonica caused by SCN4A Arg1448Cys mutation.
    Hsu WC; Huang YC; Wang CW; Hsueh CH; Lai LP; Yeh JH
    J Formos Med Assoc; 2006 Jun; 105(6):503-7. PubMed ID: 16801039
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperkalemic periodic paralysis associated with a novel missense variant located in the inner pore of Nav1.4.
    Segawa K; Nishiyama M; Mori I; Kubota T; Takahashi MP
    Brain Dev; 2023 Apr; 45(4):205-211. PubMed ID: 36628799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia.
    Song W; Shou W
    Pediatr Cardiol; 2012 Aug; 33(6):943-9. PubMed ID: 22460359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. International Union of Pharmacology. XXXIX. Compendium of voltage-gated ion channels: sodium channels.
    Catterall WA; Goldin AL; Waxman SG;
    Pharmacol Rev; 2003 Dec; 55(4):575-8. PubMed ID: 14657413
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A global defect in scaling relationship between electrical activity and availability of muscle sodium channels in hyperkalemic periodic paralysis.
    Melamed-Frank M; Marom S
    Pflugers Arch; 1999 Jul; 438(2):213-7. PubMed ID: 10370108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phenotypic variation of a Thr704Met mutation in skeletal sodium channel gene in a family with paralysis periodica paramyotonica.
    Kim J; Hahn Y; Sohn EH; Lee YJ; Yun JH; Kim JM; Chung JH
    J Neurol Neurosurg Psychiatry; 2001 May; 70(5):618-23. PubMed ID: 11309455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe infantile hyperkalaemic periodic paralysis and paramyotonia congenita: broadening the clinical spectrum associated with the T704M mutation in SCN4A.
    Brancati F; Valente EM; Davies NP; Sarkozy A; Sweeney MG; LoMonaco M; Pizzuti A; Hanna MG; Dallapiccola B
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1339-41. PubMed ID: 12933953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct repriming and closed-state inactivation kinetics of Nav1.6 and Nav1.7 sodium channels in mouse spinal sensory neurons.
    Herzog RI; Cummins TR; Ghassemi F; Dib-Hajj SD; Waxman SG
    J Physiol; 2003 Sep; 551(Pt 3):741-50. PubMed ID: 12843211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential sialylation modulates voltage-gated Na+ channel gating throughout the developing myocardium.
    Stocker PJ; Bennett ES
    J Gen Physiol; 2006 Mar; 127(3):253-65. PubMed ID: 16476705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New SCN5A mutation in a SUDEP victim with idiopathic epilepsy.
    Aurlien D; Leren TP; Taubøll E; Gjerstad L
    Seizure; 2009 Mar; 18(2):158-60. PubMed ID: 18752973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Contractile abnormalities of mouse muscles expressing hyperkalemic periodic paralysis mutant NaV1.4 channels do not correlate with Na+ influx or channel content.
    Lucas B; Ammar T; Khogali S; DeJong D; Barbalinardo M; Nishi C; Hayward LJ; Renaud JM
    Physiol Genomics; 2014 Jun; 46(11):385-97. PubMed ID: 24714718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spider toxin inhibits gating pore currents underlying periodic paralysis.
    Männikkö R; Shenkarev ZO; Thor MG; Berkut AA; Myshkin MY; Paramonov AS; Kulbatskii DS; Kuzmin DA; Sampedro Castañeda M; King L; Wilson ER; Lyukmanova EN; Kirpichnikov MP; Schorge S; Bosmans F; Hanna MG; Kullmann DM; Vassilevski AA
    Proc Natl Acad Sci U S A; 2018 Apr; 115(17):4495-4500. PubMed ID: 29636418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can common genetic variations combine to produce the long QT syndrome phenotype?
    Kaufman ES
    Heart Rhythm; 2005 Jul; 2(7):748-9. PubMed ID: 15992733
    [No Abstract]   [Full Text] [Related]  

  • 35. Restoring repolarization in LQT3.
    George AL
    Heart Rhythm; 2009 Jan; 6(1):107-8. PubMed ID: 19121809
    [No Abstract]   [Full Text] [Related]  

  • 36. Gating pore current in an inherited ion channelopathy.
    Sokolov S; Scheuer T; Catterall WA
    Nature; 2007 Mar; 446(7131):76-8. PubMed ID: 17330043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cardiac sodium channel: gating function and molecular pharmacology.
    Balser JR
    J Mol Cell Cardiol; 2001 Apr; 33(4):599-613. PubMed ID: 11273715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Long QT syndrome].
    Nakajima T; Kaneko Y; Taniguchi Y; Nagai R
    Nihon Rinsho; 1996 Mar; 54(3):776-81. PubMed ID: 8904236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel.
    Wang Q; Chen S; Chen Q; Wan X; Shen J; Hoeltge GA; Timur AA; Keating MT; Kirsch GE
    J Med Genet; 2004 May; 41(5):e66. PubMed ID: 15121794
    [No Abstract]   [Full Text] [Related]  

  • 40. Spectrum of Nondystrophic Skeletal Muscle Channelopathies in Children.
    Al-Ghamdi F; Darras BT; Ghosh PS
    Pediatr Neurol; 2017 May; 70():26-33. PubMed ID: 28325641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.